[A study of the toxicity, pharmacokinetics and pharmacodynamics of the new antitumor antibiotic carminomycin].
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity; D000903:Antibiotics, Antineoplastic / Q000633:toxicity*; D001341:Autonomic Nervous System / Q000187:drug effects; D001646:Bile / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D002360:Carubicin / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity*; D002415:Cats; D006321:Heart / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D009469:Neuromuscular Junction / Q000187:drug effects; D011485:Protein Binding; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D013154:Spleen / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D001798:Blood Proteins; D002360:Carubicin
Izuchenia toksichnosti, farmakokinetiki i farmakodinamiki novogo protivoopukholevogo antibiotika karminomitsina